Prof. Dr. Gökhan YAPRAK

1. Cardiotoxicity perspective on the concurrent use of anti-HER2 agents and hypofractionated versus conventional fractionated locoregional radiotherapy in breast cancer

Tepetam H., Varan M. P., Alomarı O., Yıldırım S., Gedik D., ODABAŞ H., et al.

BMC Cancer , cilt.26, sa.1, 2026 (SCI-Expanded, Scopus)

2. Investigation of potential biomarkers associated with relapse in cervical cancer: miRNA-320a-3p and miRNA-136-5p

Pekyürek Varan M., YAPRAK G., GÜNDÜZ K., YETMEN DOĞAN Ö., Eren M., Şahin M., et al.

Strahlentherapie und Onkologie , cilt.202, sa.4, ss.418-427, 2026 (SCI-Expanded, Scopus)

3. Cognitive Emotion Regulation and Its Impact on Sexual Function, Body Image, and Depression in Breast Cancer Survivors

Yıldırım Cinek B., Varan M. P., YAPRAK G., ALTINTAŞ M.

Psychiatry Investigation , cilt.22, sa.3, ss.330-339, 2025 (SCI-Expanded, SSCI, Scopus)

4. Preoperative Stereotactic Radiosurgery for Brain Metastases: A Single-Institution Experience

YAPRAK G., Pekyurek Varan M., Cini N., Yilmaz U., Isik N., Hicdonmez T.

Turkish Neurosurgery , cilt.35, sa.3, ss.474-483, 2025 (SCI-Expanded, Scopus, TRDizin)

5. The role of stereotactic body radiotherapy (SBRT) in the treatment of recurrent / progressive lung lesions after primary treatment

DEMİR H. A., ÖZDEMİR S., Işik N., YAPRAK G.

International Journal of Radiation Research , cilt.21, sa.4, ss.727-732, 2023 (SCI-Expanded, Scopus)

6. The Role of Stereotactic Radiotherapy for the Treatment of Melanoma and Renal Cell Carcinoma Brain Metastases

Pekyürek Varan M., YAPRAK G., Algül E., Gedik D., Işik N.

Turk Onkoloji Dergisi , cilt.38, sa.4, ss.459-465, 2023 (ESCI, Scopus, TRDizin)

7. Push-out bond strength of fiber posts to irradiated and non-irradiated intraradicular dentin

Başer Can E. D., Barut G., IŞIK ŞİŞMANOĞLU V., Algül E., YAPRAK G., Can E.

Clinical Oral Investigations , cilt.26, sa.12, ss.7057-7069, 2022 (SCI-Expanded, Scopus)

8. Factors affecting the recurrence of early-stage lip cancer

Tugrul F., Isık N., YAPRAK G.

International Journal of Radiation Research , cilt.20, sa.2, ss.323-327, 2022 (SCI-Expanded, Scopus)

9. Is there any advantage of machine learning to multivariate regression analysis for predicting disease-related deaths in patients with gastric cancer? Reevaluation of retrospective data

Kaya U., YAPRAK G., Yilmaz A., Özen A.

Turk Onkoloji Dergisi , cilt.36, sa.2, ss.184-190, 2021 (ESCI, Scopus, TRDizin)

10. Prognostic factors in medically inoperable early stage lung cancer patients treated with stereotactic ablative radiation therapy (SABR): Turkish Radiation Oncology Society Multicentric Study

Sahin B., Atalar B., Kaytan Saglam E., Akgun Z., ABACIOGLU M. U., Arifoglu A., et al.

Clinical Respiratory Journal , cilt.14, sa.11, ss.1050-1059, 2020 (SCI-Expanded, Scopus)

11. The effect of the wound healing properties of glutamine on skin toxicities and esophagitis in breast cancer radiotherapy Meme kanseri radyoterapisinde glutaminin yara iyileştirme özelliklerinin cilt toksisiteleri ve özofajit üzerine etkisi

KARABULUT GÜL Ş., Tepetam H., Bicakci B. C., Demircioglu F., YAPRAK G.

Gazi Medical Journal , cilt.31, sa.2, ss.174-177, 2020 (ESCI, Scopus)

12. Anal canal squamous cell cancer: Surgıcal therapy, when?

KAYA S., Altın O., ALTUNTAŞ Y. E., YAPRAK G., KÜÇÜK H. F.

Medicinski Glasnik , cilt.16, sa.2, ss.271-276, 2019 (Scopus)

13. Is there any prognostic significance of the level of change in SUVmax after SBRT in patients with early stage NSCLC? Erken evre akciğer kanserli hastalarda SBRT sonrası SUVmax değişiminin prognostik önemi varmı?

YAPRAK G., Ozen A., Tugrul F., Ozugur S., Isik N.

UHOD - Uluslararasi Hematoloji-Onkoloji Dergisi , cilt.29, sa.3, ss.130-138, 2019 (SCI-Expanded, Scopus, TRDizin)

14. Stereotactic body radiotherapy for adrenal gland metastases: Single-center experience

YAPRAK G., Işik N., Gemici C., Demir H., Pekyürek M.

Turk Onkoloji Dergisi , cilt.34, sa.4, ss.291-297, 2019 (Scopus, TRDizin)

Prof. Dr. Gökhan YAPRAK

Yayınlar & Eserler

1. Cardiotoxicity perspective on the concurrent use of anti-HER2 agents and hypofractionated versus conventional fractionated locoregional radiotherapy in breast cancer

2. Investigation of potential biomarkers associated with relapse in cervical cancer: miRNA-320a-3p and miRNA-136-5p

3. Cognitive Emotion Regulation and Its Impact on Sexual Function, Body Image, and Depression in Breast Cancer Survivors

4. Preoperative Stereotactic Radiosurgery for Brain Metastases: A Single-Institution Experience

5. The role of stereotactic body radiotherapy (SBRT) in the treatment of recurrent / progressive lung lesions after primary treatment

6. The Role of Stereotactic Radiotherapy for the Treatment of Melanoma and Renal Cell Carcinoma Brain Metastases

7. Push-out bond strength of fiber posts to irradiated and non-irradiated intraradicular dentin

8. Factors affecting the recurrence of early-stage lip cancer

9. Is there any advantage of machine learning to multivariate regression analysis for predicting disease-related deaths in patients with gastric cancer? Reevaluation of retrospective data

10. Prognostic factors in medically inoperable early stage lung cancer patients treated with stereotactic ablative radiation therapy (SABR): Turkish Radiation Oncology Society Multicentric Study

11. The effect of the wound healing properties of glutamine on skin toxicities and esophagitis in breast cancer radiotherapy Meme kanseri radyoterapisinde glutaminin yara iyileştirme özelliklerinin cilt toksisiteleri ve özofajit üzerine etkisi

12. Anal canal squamous cell cancer: Surgıcal therapy, when?

13. Is there any prognostic significance of the level of change in SUVmax after SBRT in patients with early stage NSCLC? Erken evre akciğer kanserli hastalarda SBRT sonrası SUVmax değişiminin prognostik önemi varmı?

14. Stereotactic body radiotherapy for adrenal gland metastases: Single-center experience

Yayın

Yayın (WoS)

Yayın (Scopus)

H-İndeks (WoS)

Atıf (Scopus)

H-İndeks (Scopus)

Tez Danışmanlığı

Açık Erişim